Technologies & Platforms Overview

Powering Innovation, Driving Results

Eurofins DiscoverX, an innovative biotechnology company, develops, manufactures, and commercializes cell lines, reagents, complete assay kits, and turn-key solutions for the drug discovery, screening, and life science markets. Our products, biochemical and cell-based assays, enable customers to improve research productivity and effectiveness, thus accelerating the discovery and development of new drugs.

Proven Technology Platforms

Enzyme Fragment Complementation (EFC) patented technology, established in diagnostics, is enhanced to provide solutions to drug discovery research. EFC offers the means to interrogate biomolecular reactions for advancing therapeutic drug and screening programs.

BioMAP platform for human primary cell screening and profiling is the broadest, most physiologically relevant method to quickly and robustly determine the efficacy, safety, and mechanism of action (MOA) of candidate drug molecules to support their pipeline progression.

Eurofins DiscoverX's proprietary active-site/ligand competitive binding technology affords investigators the ability to leverage a comprehensive array of services against multiple target classes and maximixe the value of novel and chemistry assets through all stages of drug discovery.